Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,712 | 101,629 | 121,986 | 139,533 | 156,184 |
| Receivables | 573 | 18,304 | 3,343 | 6,166 | 4,934 |
| Inventories | N/A | 10,166 | 9,472 | 9,054 | 9,502 |
| Other current assets | 26,435 | 0 | 0 | 0 | 0 |
| TOTAL | $119,889 | $134,867 | $139,772 | $160,115 | $174,838 |
| Non-Current Assets | |||||
| PPE Net | 35,109 | 64,980 | 68,190 | 71,003 | 71,828 |
| Intangibles | 0 | 7,518 | 7,624 | 7,945 | 7,775 |
| Other Non-Current Assets | 14,012 | 2,883 | 2,261 | 2,301 | 2,351 |
| TOTAL | $49,121 | $75,381 | $78,075 | $81,249 | $81,954 |
| Total Assets | $169,010 | $210,248 | $217,847 | $241,364 | $256,792 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,676 | 26,832 | 21,841 | 21,773 | 22,207 |
| Accrued Expenses | 3,883 | 7,776 | 9,507 | 3,349 | 3,286 |
| Other current liabilities | 46,392 | N/A | N/A | N/A | N/A |
| TOTAL | $63,879 | $60,508 | $54,610 | $50,473 | $49,896 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,410 | 22,522 | 20,021 | 22,243 | 21,425 |
| Other Non-Current Liabilities | 1,079 | 975 | 835 | 0 | 470 |
| TOTAL | $64,736 | $145,663 | $149,678 | $153,333 | $153,354 |
| Total Liabilities | $128,615 | $206,171 | $204,288 | $203,806 | $203,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,547 | 24,331 | 24,326 | 24,304 | 24,287 |
| Common Shares | 2 | 24 | 24 | 24 | 24 |
| Retained earnings | -1,398,736 | -1,437,308 | -1,424,951 | -1,397,768 | -1,376,220 |
| Other shareholders' equity | -2,608 | 1,616 | 173 | 1,412 | -1,179 |
| TOTAL | $40,395 | $4,077 | $13,559 | $37,558 | $53,542 |
| Total Liabilities And Equity | $169,010 | $210,248 | $217,847 | $241,364 | $256,792 |